51
2
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP1181 | Bradykinin (2-9) | Des-Arg1-bradykinin | Bradykinin Receptor |
Bradykinin (2-9) (Des-Arg1-bradykinin) is an amino-truncated peptide compound that is a metabolite of Bradykinin. It is formed by the cleavage action of Aminopeptidase P. | |||
TP1445 | [Des-Arg9]-Bradykinin acetate | Bradykinin Receptor | |
[Des-Arg9]-Bradykinin acetate is a selective agonist of Bradykinin B1 receptor. | |||
TP1277 | Bradykinin | Endogenous Metabolite , Bradykinin Receptor | |
Bradykinin is an inflammatory mediator. It is a peptide that causes blood vessels to dilate (enlarge) via the release of prostacyclin, nitric oxide, and Endothelium-Derived Hyperpolarizing Factor. Bradykinin is a physiol... | |||
T5048 | SSR240612 | Bradykinin Receptor | |
SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.73 and 358-481 nM for B1 and B2 receptors, respectively). | |||
T22344 | Icatibant Acetate | Bradykinin Receptor | |
Icatibant Acetate, an antagonist of the bradykinin B2 receptor, is used in the treatment of hereditary angioedema. | |||
T2086 | ELN-441958 | ELN 441958 | Bradykinin Receptor |
ELN-441958 is a potent, neutral antagonist of B1 receptor, inhibits the binding of the B1 agonist ligand [3H]DAKD to IMR-90 cells with Ki of 0.26 nM. ELN-441958(ELN 441958) is highly selective for B1 over B2 receptors. | |||
T7645 | [Des-Arg9]-Bradykinin | [Des-Arg9]-Bradykinin(2TFA) | Bradykinin Receptor |
[Des-Arg9]-Bradykinin ([Des-Arg9]-Bradykinin(2TFA))(2TFA) is an agonist of Bradykinin (B1) receptor. | |||
TP2268L | Lys-Bradykinin acetate(342-10-9 free base) | Bradykinin Receptor | |
Lys-Bradykinin acetate is an endogenous bradykinin receptor agonist. | |||
T8809 | [Des-Arg9]-Bradykinin TFA | Bradykinin Receptor | |
[Des-Arg9]-Bradykinin is an agonist of Bradykinin (B1) receptor that displays selectivity for B1 over B2 receptors. | |||
T33421 | MK-0686 | MK0686 | Bradykinin Receptor |
MK-0686 is an orally available bradykinin B1 receptor antagonist with potential anti-inflammatory activity. | |||
T36442L | (Hyp³)-Bradykinin acetate | (Hyp³)-Bradykinin acetate (37642-65-2 Free base) | Bradykinin Receptor |
(Hyp³)-Bradykinin acetate is an agonist of bradykinin B2 receptor and stimulates inositol phosphate production in cultured human fibroblasts. | |||
TP2075L | Bombinakinin M acetate | Bombinakinin M acetate(509151-65-9 free base) | Bradykinin Receptor |
Bombinakinin M acetate is a potent bradykinin receptor agonist with high selectivity for mammalian arterial smooth muscle bradykinin receptors and is approximately 50 times more potent than bradykinin. | |||
TP1918L1 | Lys-[Des-Arg9]Bradykinin acetate | Lys-[Des-Arg9]Bradykinin acetate (71800-36-7 free base) | Bradykinin Receptor |
Lys-[Des-Arg9]Bradykinin acetate is an endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces p... | |||
TP1918L | Lys-[Des-Arg9]Bradykinin,TFA | Lys-[Des-Arg9]Bradykinin,TFA 71800-36-7(fb-tfa) | Bradykinin Receptor |
Lys-[Des-Arg9]Bradykinin,TFA is Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripher... | |||
T34485 | Safotibant | LF220542,LF 220542,LF 22-0542,LF-220542,LF-22-0542,LF22-0542 | Bradykinin Receptor |
Safotibant (LF-22-0542) is a bradykinin B1 receptor antagonist with anti-inflammatory and analgesic activity for the topical treatment of diabetic macular edema. | |||
TP1917L1 | Sar-[D-Phe8]-des-Arg9-Bradykinin acetate | Sar-[D-Phe8]-des-Arg9-Bradykinin acetate(126959-88-4 free base) | Bradykinin Receptor |
Sar-[D-Phe8]-des-Arg9-Bradykinin acetate is a potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cl... | |||
T26627L | Anatibant 2HCl | Anatibant 2HCl(209733-45-9 Free base) | Bradykinin Receptor |
Anatibant 2HCl is a small molecule bradykinin B2 receptor antagonist for the treatment of neurological disorders and may be used in the study of brain injury. | |||
TP1933 | R715 TFA(185052-09-9 free base) | R 715 | Bradykinin Receptor |
R715 TFA(185052-09-9 free base) is a potent and selective bradykinin B1 receptor antagonist (pA2 = 8.49). Displays no activity at B2 receptors. Reduces mechanical hypernociception in a mouse model of neuropathic pain. Me... | |||
TP1931L1 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate(96736-12-8 free base) | cholecystokinin |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate ([D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P acetate (96736-12-8 free base)) is a broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist ... | |||
T4200 | Sacubitril hemicalcium salt | AHU-377 (hemicalcium salt),AHU377 calcium salt | Neprilysin |
Sacubitril hemicalcium salt (AHU377 calcium salt) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril hemicalcium salt is a component of the heart failure medicine LCZ696. Sacubitril hemicalcium salt is a prodrug ... | |||
T15347 | FR167344 free base | Others | |
FR167344 free base is an orally active and nonpeptide antagonist of bradykinin receptor B2. FR167344 free base displays a high-affinity binding to the B2 receptor (IC50: 65 nM). It has no binding affinity for the B1 rece... | |||
T27377 | FR190997 | FR-190997,FR 190997 | |
FR190997 is an agonist of bradykinin B2 receptor. | |||
T70750 | Deltibant | ||
Deltibantis a bradykinin receptor antagonist. | |||
T21060 | NPC 567 | ||
NPC 567 is an antagonist of the bradykinin receptor. | |||
T69673 | Deucrictibant | ||
Deucrictibant is a bradykinin receptor antagonist. | |||
T70576 | NPC 17731 | ||
NPC 17731 is a bradykinin receptor antagonist. | |||
T70574 | NPC 17761 | ||
NPC 17761 is a bradykinin receptor antagonist. | |||
T63241 | Fulimetibant | ||
Fulimetibant is a bradykinin receptor antagonist. | |||
T80117 | Lys-(Des-Arg9,Leu8)-Bradykinin | Bradykinin Receptor | |
Lys-(Des-Arg9,Leu8)-Bradykinin is a selective antagonist of the bradykinin B1 receptor [1]. | |||
T25895 | NVP-SAA164 | SAA 164,SAA164,SAA-164,NVP SAA164 | |
NVP-SAA164 is a nonpeptide bradykinin B1 receptor antagonist agent. | |||
T25555 | JMV-1645 | JMV1645,JMV 1645 | |
JMV-1645 is an effective and selective B(1) bradykinin receptor antagonist. | |||
T24065 | FK-3657 | FK 3657,FK3657,FR-173657,FR 173657,FR173657 | |
FK-3657 is a non-peptide antagonist of bradykinin (BK)-B2 receptor. | |||
T15547 | Icatibant | HOE 140 | Others |
Icatibant is a selective and specific antagonist of the bradykinin B2 receptor (IC50 and Ki: 1.07 nM and 0.798 nM respectively). | |||
TP2076 | [Phe8Ψ(CH-NH)-Arg9]-Bradykinin | ||
Selective bradykinin B2 receptor agonist that is resistant to carboxypeptidase cleavage. 5-fold more potent and exhibits a more prolonged duration of action than bradykinin in vivo. | |||
TP2075 | Bombinakinin M | ||
Potent bradykinin receptor agonist. Highly selective for mammalian arterial smooth muscle bradykinin receptors, displaying ~ 50-fold greater potency than bradykinin. Elicits dose-dependent contractile effects in smooth m... | |||
TP2268 | Lys-Bradykinin | Others | |
Endogenous bradykinin receptor agonist | |||
T80072 | Des-Arg9-[Leu8]-Bradykinin acetate | Bradykinin Receptor | |
Des-Arg9-[Leu8]-Bradykinin acetate is a potent antagonist of the bradykinin receptor 1 (B1R), utilized in renal fibrosis research [1]. | |||
T76385 | [Tyr8] Bradykinin | ||
[Tyr8] Bradykinin, a B2 kinin receptor agonist, not only stimulates ERK1/2 phosphorylation but also serves as an internal standard [1]. | |||
TP1918 | Lys-[Des-Arg9]Bradykinin | ||
Endogenous potent and highly selective bradykinin B1 receptor agonist (Ki values are 0.12 and > 30000 nM at human B1 and B2 receptors respectively). Hypotensive agent that reduces peripheral vascular resistance in vivo. ... | |||
T76212 | B 9430 | ||
B 9430 is a potent bradykinin B1/B2 receptor antagonist [1] . | |||
T27790 | Labradimil | RMP-7,ALK-01-040,Receptor-mediated permeabiliser-7,DRG0182,DRG 0182,DRG-0182 | |
Labradimil is a bradykinin B2 receptor agonist. Labradimil increases the permeability of human brain microvascular endothelial cell monolayers. Labradimil enhances delivery of hydrophilic chemotherapeutics and increases ... | |||
T83500 | [Des-Arg10]-HOE I40 | ||
[Des-Arg10]-HOE 140 is a bioactive peptide that functions as a potent B1 bradykinin receptor antagonist. | |||
T38544 | Fasitibant chloride | MEN16132 free base,Fasitibant chloride | |
Fasitibant chloride (MEN16132 free base) is a powerful and specific nonpeptide antagonist of the bradykinin B2 receptor (B2R). This compound effectively reduces joint pain and mitigates joint edema in a rat model of Carr... | |||
T73646 | Lys-[Des-Arg9]Bradykinin TFA | ||
Lys-[Des-Arg9]Bradykinin TFA is a naturally occurring kinin that serves as a potent and highly selective agonist for the bradykinin B1 receptor, demonstrating binding affinities (K i values) of 0.12 nM, 1.7 nM, and 0.23 ... | |||
TP1931 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | ||
Broad spectrum neuropeptide inverse agonist and antagonist. Potent full inverse agonist for the ghrelin receptor (EC50 = 5.2 nM); diminishes constitutive ghrelin receptor signaling. Also antagonist at tachykinin, bradyki... | |||
TP1917 | Sar-[D-Phe8]-des-Arg9-Bradykinin | ||
Potent and selective bradykinin B1 receptor agonist (EC50 = 9.02 nM in rabbit aorta) that is resistant to aminopeptidase, kininase I and II (ACE) and neutral endopeptidase cleavage. Exhibits hypotensive and angiogenic ac... | |||
TP1999 | MEN 11270 | ||
Peptide antagonist of the B2 bradykinin receptor (pKi = 10.3); conformationally constrained cyclized analog of HOE 140. Blocks hypotension and bronchoconstriction in vivo. Displays selectivity for B2 over 29 other recept... | |||
T26627 | Anatibant | LF16-0687,LF-16-0687,LF 160687,LF 16-0687,LF-160687 | |
Anatibant is a potent non-peptide bradykinin B2 receptor antagonist. Anatibant reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. | |||
TP2126 | R 892 | ||
Potent and selective bradykinin B1 receptor antagonist (ID50 values are 2.8 and > 600 nM at B1 and B2 receptors respectively). Exhibits no intrinsic agonist activity and is resistant to aminopeptidase and kininase II (AC... | |||
TP1662 | Galanin Receptor Ligand M35 | ||
The chimeric peptide M35 [galanin (1-13)-bradykinin(2-9) amide] is a high-affinity galanin receptor ligand acting as a galanin receptor antagonist in the rat spinal cord, rat hippocampus and isolated mouse pancreatic isl... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03081 | ACE2 Protein, Paguma larvata, Recombinant (hFc) | Paguma larvata | HEK293 |
Essential counter-regulatory carboxypeptidase of the renin-angiotensin hormone system that is a critical regulator of blood volume, systemic vascular resistance, and thus cardiovascular homeostasis. Converts angiotensin ... | |||
TMPY-00410 | EPHX2 Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
Genetic variation in EPHX2 was significantly associated with risk of incident CHD in Caucasians, implicating EPHX2 as a potential cardiovascular disease-susceptibility gene. Single nucleotide polymorphisms (SNPs) in the ... |
Cat No. | Product Name | ||
---|---|---|---|
L7110 | Anti-Hypertension Compound Library | 719 compounds | |
719 hypertension-related small molecules for high-throughput and high-content screening. |